LOXO-305 Comes Out Swinging In Battle Of BTK Inhibitors

Lilly's Loxo Presents Positive Phase I/II Data In MCL At ASH

 
• By Alaric DeArment
Digital illustration of Cancer cell in colour background
Loxo Oncology at Lilly announces MCL data from Phase I/II study at ASH • Source: Shutterstock

More from Clinical Trials

More from R&D